Department of Pharmacy Practice, Unaizah College of Pharmacy, Qassim University, Qassim, Saudi Arabia.
Saudi J Kidney Dis Transpl. 2020 Mar-Apr;31(2):454-459. doi: 10.4103/1319-2442.284021.
Studies directed toward improving the life quality of hemodialysis (HD) patients revealed different etiologies for insomnia. We aimed to assess the prevalence of insomnia and determine associated etiologies in the AL Qassim region. This interview-based questionnaire study was conducted in HD centers for assessment of insomnia and its related causes using a validated screening questionnaire, developed by the JPS health network. Accordingly, patients were classified as insomnia, insomnia for further evaluation and management and no insomnia. Of 111 patients, there were 55 males and 56 females. The prevalence of primary insomnia was 28.82%, compared to 44% for secondary insomnia. Significant correlations linked insomnia with apnea, night itching, and not using phosphate binder usage. Primary and secondary insomnia is frequent among dialysis patients and require an application of diagnostic tools and severity scales. The assessment of causes and treatment of the complaints of apnea, usage of phosphate binders, and itching should be considered to decrease complications and improve quality of life.
研究旨在提高血液透析（HD）患者的生活质量，揭示了失眠的不同病因。我们旨在评估在 Al Qassim 地区失眠的患病率，并确定相关病因。这项基于访谈的问卷调查研究在 HD 中心进行，使用由 JPS 健康网络开发的经过验证的筛选问卷评估失眠及其相关原因。相应地，患者被分为失眠、需要进一步评估和管理的失眠以及没有失眠。在 111 名患者中，有 55 名男性和 56 名女性。原发性失眠的患病率为 28.82%，而继发性失眠的患病率为 44%。失眠与呼吸暂停、夜间瘙痒和不使用磷酸盐结合剂显著相关。透析患者中经常出现原发性和继发性失眠，需要应用诊断工具和严重程度量表。应考虑评估呼吸暂停、磷酸盐结合剂使用和瘙痒的原因，并进行治疗，以减少并发症并提高生活质量。
